Insulet Corporation (NASDAQ:PODD) Q2 2023 Earnings Conference Call August 8, 2023 4:30 PM ET

Company Participants

Deborah Gordon - VP, IR

James Hollingshead - President, CEO & Director

Wayde McMillan - EVP, CFO & Treasurer

Conference Call Participants

Lawrence Biegelsen - Wells Fargo Securities

Robert Marcus - JPMorgan Chase & Co.

Malgorzata Kaczor - William Blair & Company

Joshua Jennings - TD Cowen

Danielle Antalffy - UBS

Jeffrey Johnson - Robert W. Baird & Co.

Michael Sarcone - Jefferies

Christopher Pasquale - Nephron Research

Matthew O'Brien - Piper Sandler & Co.

Matthew Miksic - Barclays Bank

Steven Lichtman - Oppenheimer

Joanne Wuensch - Citigroup

Doyle Shell - Raymond James & Associates

Travis Steed - Bank of America Merrill Lynch

Operator

Good afternoon, ladies and gentlemen, and welcome to the Insulet Corporation Second Quarter 2023 Earnings Call. [Operator Instructions].

I would now like to turn the conference over to your host, Deborah Gordon, Vice President, Investor Relations.

Deborah Gordon

Thank you. Good afternoon, and thank you joining us for Insulet's Second Quarter 2023 Earnings Call. With me today are Jim Hollingshead, President and Chief Executive Officer; and Wayde McMillan, Executive Vice President and Chief Financial Officer.

Both the replay of this call and the press release discussing our quarterly results and our guidance will be available on the Investor Relations section of our website. Also on our website is our second quarter supplemental earnings presentation. We encourage you to reference that document for a summary of key metrics and business updates.

Before we begin, we would like to inform you that certain statements made by Insulet during the course of this call may be forward-looking and could materially differ from current expectations. Please refer to the cautionary statements in our SEC filings for a detailed explanation of the inherent limitations of such statements. We'll also discuss non-GAAP financial measures with respect to our performance, namely adjusted gross and operating margins, adjusted EBITDA and constant currency revenue, which is revenue growth excluding the effect of foreign exchange.

These measures align with what management uses as supplemental measures in assessing our operating performance, and we believe they are helpful to investors, analysts and other interested parties as measures of our operating performance from period to period. Additionally, unless otherwise stated, all financial commentary regarding dollar and percentage changes will be on a year-over-year reported basis, with the exception of revenue growth rates, which will be on a year-over-year constant currency basis.